Zurück zur Hauptseite

Unternehmen auf Beobachtungsliste setzen

Marinomed Biotech AG

ISIN: ATMARINOMED6

WKN: A2N9MM

Über

Snapshot Unternehmen

Neu: Benachrichtigung aktivieren

Aktuelle Nachrichten per Alarm empfangem

Neu: KI-Factsheet

Coming soon: Zusammenfassung der Unternehmensnachricht durch KI/p>

Marinomed Biotech AG · ISIN: ATMARINOMED6 · Newswire (adhoc)

Land: Österreich · Primärmarkt: Österreich · EQS NID: 1968247

Levermann Score

14 August 2024 15:35PM

Court opens restructuring proceedings without self-administration

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange.

+++ End of ad-hoc announcement +++

End of Inside Information

14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com

Language:	English
Company:	Marinomed Biotech AG
	Hovengasse 25
	2100 Korneuburg
	Austria
Phone:	+43 2262 90300
E-mail:	office@marinomed.com
Internet:	www.marinomed.com
ISIN:	ATMARINOMED6
WKN:	A2N9MM
Listed:	Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market)
EQS News ID:	1968247


End of Announcement	EQS News Service

1968247 14-Aug-2024 CET/CEST

Research & Analysen